Back to Search

SUNANDA NABHA, MD

MD

Emergency Medicine Physician

NPI: 1467430173Individual

Specialties, Licenses & Credentials

Emergency Medicine PhysicianPrimary

Emergency Medicine

Code: 207P00000X

C10001866(DE)

Research & Publications (15)

Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner.
PMID 18324629·Int J Cancer·2008
8-other
Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasis.
PMID 17136575·Clin Exp Metastasis·2006
7-preclinical
Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cells.
PMID 15735693·Oncogene·2005
7-preclinical
Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.
PMID 12171907·Clin Cancer Res·2002
8-other
Evaluation of combretastatin A-4 prodrug in a non-Hodgkin's lymphoma xenograft model: preclinical efficacy.
PMID 11272287·Anticancer Drugs·2001
7-preclinical
Effects of combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines.
PMID 10912955·Anticancer Drugs·2000
8-other
C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasis.
PMID 18714401·Neoplasia·2008
7-preclinical
Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover.
PMID 18472961·Neoplasia·2008
7-preclinical
Paradoxical antiproliferative effect by a murine mammary tumor-derived epithelial cell line.
PMID 17908302·BMC Cancer·2007
7-preclinical
Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth.
PMID 17525276·Am J Pathol·2007
7-preclinical
Heterogeneous activation of MMP-9 due to prostate cancer-bone interaction.
PMID 17445684·Urology·2007
7-preclinical
Quantitative assessment of small intraosseous prostate cancer burden in SCID mice using fluorescence imaging.
PMID 17075820·Prostate·2007
4-observational
Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor.
PMID 16381009·Int J Cancer·2006
7-preclinical
Role of MAP kinase in tumor progression and invasion.
PMID 12884914·Cancer Metastasis Rev·2003
6-review
Rituximab, Cyclophosphamide, Dexamethasone (RCD) regimen induces cure in WSU-WM xenograft model and a partial remission in previously treated Waldenstrom's macroglobulinemia patient.
PMID 12442811·J Drug Target·2002
5-case

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
4755 OGLETOWN STANTON RD
NEWARK, DE 19718

Location

Practice Location

4755 OGLETOWN STANTON RD, NEWARK, DE
(302) 733-1000

Quick Facts

NPI
1467430173
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
15

Are you this provider?

Claim Your Profile